Pathophysiology

Citations 351-360 of 1272 total displayed.

Past content (since Jan 1999):

Articles
Extracellular Matrix Metalloproteinase Inducer Regulates Matrix Metalloproteinase Activity in Cardiovascular Cells. Implications in Acute Myocardial Infarction: Roland Schmidt, Andreas Bültmann, Martin Ungerer, Nader Joghetaei, Özgür Bülbül, Sven Thieme, Triantafyllos Chavakis, Bryan P. Toole, Meinrad Gawaz, Albert Schömig, and Andreas E. May
Circulation published February 6, 2006, doi:10.1161/CIRCULATIONAHA.105.568162 [Abstract]

Images in Cardiovascular Medicine
Role of Inflammation in Atherosclerosis: Immunohistochemical and Electron Microscopic Images of a Coronary Endarterectomy Specimen: Komarakshi R. Balakrishnan and Sarah Kuruvilla
Circulation 2006;113:e41-43e, doi:10.1161/CIRCULATIONAHA.105.537464 [Full text]

Basic Science for Clinicians
Physiological Basis of Clinically Used Coronary Hemodynamic Indices: Jos A.E. Spaan, Jan J. Piek, Julien I.E. Hoffman, and Maria Siebes
Circulation 2006;113:446-455, doi:10.1161/CIRCULATIONAHA.105.587196 [Abstract] [Full text]

Vascular Medicine
Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation: E. Lutgens, S.P.M. Lutgens, B.C.G. Faber, S. Heeneman, M.M.J. Gijbels, M.P.J. de Winther, P. Frederik, I. van der Made, A. Daugherty, A.M. Sijbers, A. Fisher, C.J. Long, P. Saftig, D. Black, M.J.A.P. Daemen, and K.B.J.M. Cleutjens
Circulation 2006;113:98-107; published online before print as doi:10.1161/CIRCULATIONAHA.105.561449 [Abstract] [Full text]

Contemporary Reviews in Cardiovascular Medicine
What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection: Priscilla Y. Hsue and David D. Waters
Circulation 2005;112:3947-3957, doi:10.1161/CIRCULATIONAHA.105.546465 [Abstract] [Full text]

Articles
Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation: E. Lutgens, S. P.M. Lutgens, B. C.G. Faber, S. Heeneman, M. M.J. Gijbels, M. P.J. de Winther, P. Frederik, I. van der Made, A. Daugherty, A. M. Sijbers, A. Fisher, C. J. Long, P. Saftig, D. Black, M. J.A.P. Daemen, and K. B.J.M. Cleutjens
Circulation published December 19, 2005, doi:10.1161/CIRCULATIONAHA.105.561449 [Abstract]

Special Reports
Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses: Pascal J. Goldschmidt-Clermont, Mark A. Creager, Douglas W. Lorsordo, Gregory K.W. Lam, Momtaz Wassef, and Victor J. Dzau
Circulation 2005;112:3348-3353, doi:10.1161/CIRCULATIONAHA.105.577460 [Full text]

Epidemiology
Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study: Ann Smith, Chris Patterson, John Yarnell, Ann Rumley, Yoav Ben-Shlomo, and Gordon Lowe
Circulation 2005;112:3080-3087, doi:10.1161/CIRCULATIONAHA.105.557132 [Abstract] [Full text]

Vascular Medicine
The Thromboxane A₂ Receptor Antagonist S18886 Prevents Enhanced Atherogenesis Caused by Diabetes Mellitus: Adriana Zuccollo, Chaomei Shi, Roberto Mastroianni, Karlene A. Maitland-Toolan, Robert M. Weisbrod, Mengwei Zang, Shanqin Xu, Bingbing Jiang, Jennifer M. Oliver-Krasinski, Antonio J. Cayatte, Stefano Corda, Gilbert Lavielle, Tony J. Verbeuren, and Richard A. Cohen
Circulation 2005;112:3001-3008; published online before print as doi:10.1161/CIRCULATIONAHA.105.581892 [Abstract] [Full text]

Vascular Medicine
Involvement of Thromboxane Receptor in the Proatherogenic Effect of Isoprostane F₂-III: Evidence From Apolipoprotein E– and LDL Receptor–Deficient Mice: Myan Tang, Tillmann Cyrus, Yuemang Yao, Luigina Vocun, and Domenico Praticò
Circulation 2005;112:2867-2874, doi:10.1161/CIRCULATIONAHA105.562223 [Abstract] [Full text]

Subspecialty Collections Home

Show Pathophysiology
collections from other journals.

Related collections:
Atherosclerosis
Pathophysiology
Risk Factors
Other arteriosclerosis